Let me start by saying that I have nothing against
Let me start by saying that I have nothing against speculation etc since that’s one of the foundations it seems of the OTC. When you can wait decades for your stock to hit, and during that wait all there is to do is speculate.
Now the speculation going on on the other board I think is quite dangerous. Speculating and basically saying the at Univec will make you a BILLIONAIRE if you have 2 million shares and make you a MILLIONAIRE if you have 2,000 shares, or something like that, or if you just own shares. Dangerous talk.
Do we even know what we are invested in?
Do we even know what Univec is?
Do we even know the finer details of any said partnerships Univec has? In what capacity is the financial compensation for those said partnerships?
Do we know anything about the telehealth platform Univec is supposed to own?
Do we know any info on how EagleForce and others we assume Univec controls or majority stake in etc?
Do we have any information writing in ink on paper that we can reference?
If I walked into J P Morgan looking for advice and to open an account. And I tell them I expect to be a billionaire because I own Univec stock. I am pretty sure I would be quickly escorted out, after they looked at the Univec profile and PPS on the OTC Market website. I would have no factual reference to share and explain. All I could do is direct them to Dr Daltons posts on LinkedIn and Twitter and to the not complete Univec Health website.
Speculating that Univec is going to make you a billionaire from where we stand now is dangerous speak. Gets people excited but will extend people more into trying to buy and buy still having no information or direction or time line. 2019? No, 2020? No, 2021? No, 2022? No, 2023? No again. 2024? Who knows.
6
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
Top 5 Most Recently Viewed Articles
Weddings Shaping Up to Be About More Than Just 'I Do' Anyone who's been to a wedding lately knows the game's changed. Lily & Lime dropped some eye-opening insights on how couples are tossing out the old rulebook and making weddings about something much more real and raw. Forget the cookie-cutter hullabaloo—we're talking personalized celebrations now. Finally, some...
Continue Reading
Tutor Perini Corporation made headlines with its stock reaching a 52-week high of $27.06 back in 2024, reflecting a staggering rise of 242.27% over the year. You know how it goes when a company like this gets hot in the construction sector—investors pile on, chasing that momentum. Strong Q2 Surge: Earnings Play or Just Hype? The second quarter brought a significant 10%...
Continue Reading
Understanding McGrath RentCorp's Current Market Position In today's market, McGrath RentCorp Inc. (NASDAQ: MGRC) stands at a price of $96.27, marking a slight increase of 0.40%. Despite this recent uptick, the stock has seen a decline of 12.14% in the last month and a more significant drop of 17.19% over the past year. Investors are keen to assess whether the stock is...
Continue Reading
Phoenix Motor Inc. Receives Nasdaq Compliance Notification Phoenix Motor Inc. (NASDAQ:PEV), a dynamic player in the electric vehicle (EV) manufacturing sector, is facing compliance issues after receiving a delinquency notice from Nasdaq. This notification arises from the company's inability to submit its quarterly financial report on time, which is a violation of Nasdaq...
Continue Reading
Adjusted Dividend Payment Schedule for Shareholders Converge Technology Solutions Corp. (CTS) has made an important announcement regarding its dividend payment schedule. Originally set for December 28, 2024, the company has moved the payment date one day earlier, to December 27, 2024. This decision was made to ensure that shareholders receive their payments ahead of the...
Continue Reading